Home
Products
Learn
About
Pricing
Log In
CHL
Asset Logo

Camplify Holdings Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 9.78%
Annual Growth

4 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

17
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Camplify Holdings Ltd. operates in the RV rental market. The firm has built a platform that delivers transparent experiences for consumers and RV hirers to connect with RV owners and small and medium-sized enterprises (SMEs) with a fleet of RVs. Its businesses include Camplify and PaulCamper. Its segments include Hire, Membership and Other. The firm provides a range of caravans, motorhomes, camper trailers and campervans for hire via the respective platforms. The firm has operations in Australia, New Zealand, Spain, United Kingdom, Germany, Austria and Netherlands. Its subsidiaries include Camplify Co (Australia) Pty Ltd, Camplify Co (NZ) Limited, Camplify Co (UK) Limited, Plataforma Camplify Espana, S.L and PaulCamper GmbH.

๐Ÿ“ˆ Performance

Price History

+37.32%

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$1.95

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in CHL

17

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in CHL

708 days
CHL investor breakdown
๐Ÿ’ต Income of investors

More than 200k

9%

150k - 200k

100k - 150k

17%

50k - 100k

35%

Less than 50k

30%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

47%

35 - 90

47%
๐Ÿ™‹ Legal gender of investors

Female

53%

Male

47%

Pearlers who invest in CHL also invest in...

Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ“Š Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ“Š Share price

$104.08 AUD

NULL GLOBAL

NULL EX AUSTRALIA

NULL BETA

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

๐Ÿ“Š Share price

$57.36 AUD

NULL GLOBAL

NULL SMART BETA

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ“Š Share price

$43.11 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

Qantas Airways Ltd. provides air transportation services. The company is headquartered in Mascot, New South Wales. The firm is focused on the operation of international and domestic air transportation services, the provision of freight services, and the operation of a frequent flyer loyalty program. The firm's segments include Qantas Domestic, Qantas International, Jetstar Group and Qantas Loyalty. The Qantas Domestic, Qantas International, and Jetstar Group are engaged in passenger flying business and air cargo and express freight businesses. The Qantas Loyalty segment is engaged in the customer loyalty recognition programs. Its main business is the transportation of customers using two airline brands, which include Qantas and Jetstar. Its airline brands operate in regional, domestic and international services. The firm operates in Australia, New Zealand, South Pacific, Asia, Europe, North and South America, and Africa.

๐Ÿ“Š Share price

$6.51 AUD

NULL AIRLINES

Want more shares? Try these...

Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The firm is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.

๐Ÿ“Š Share price

$0.04 AUD

๐Ÿ“Š Share price

$0.00 AUD
Compare
Add to watchlist